BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28941992)

  • 1. Nano-delivery system targeting to cancer stem cell cluster of differentiation biomarkers.
    Mokhtarzadeh A; Hassanpour S; Vahid ZF; Hejazi M; Hashemi M; Ranjbari J; Tabarzad M; Noorolyai S; de la Guardia M
    J Control Release; 2017 Nov; 266():166-186. PubMed ID: 28941992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.
    Malhi S; Gu X
    Expert Opin Drug Deliv; 2015 Jul; 12(7):1177-201. PubMed ID: 25601619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of cancer stem cells in cancer drug development and drug delivery.
    Chow EK
    J Lab Autom; 2013 Feb; 18(1):6-11. PubMed ID: 22893634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine strategies for sustained, controlled and targeted treatment of cancer stem cells.
    Gao J; Li W; Guo Y; Feng SS
    Nanomedicine (Lond); 2016 Dec; 11(24):3261-3282. PubMed ID: 27854161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine-mediated cancer stem cell therapy.
    Shen S; Xia JX; Wang J
    Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cells, metabolism, and therapeutic significance.
    Yang M; Liu P; Huang P
    Tumour Biol; 2016 May; 37(5):5735-42. PubMed ID: 26864589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine-mediated drug targeting of cancer stem cells.
    Singh D; Minz AP; Sahoo SK
    Drug Discov Today; 2017 Jun; 22(6):952-959. PubMed ID: 28435061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cell characteristics and their potential as therapeutic targets.
    Lim JR; Mouawad J; Gorton OK; Bubb WA; Kwan AH
    Med Oncol; 2021 May; 38(7):76. PubMed ID: 34050825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained expression of the RON receptor tyrosine kinase by pancreatic cancer stem cells as a potential targeting moiety for antibody-directed chemotherapeutics.
    Padhye SS; Guin S; Yao HP; Zhou YQ; Zhang R; Wang MH
    Mol Pharm; 2011 Dec; 8(6):2310-9. PubMed ID: 22014215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Cancer Stem Cells: Therapeutic and diagnostic strategies by the virtue of nanoparticles.
    Shrestha S; Banstola A; Jeong JH; Seo JH; Yook S
    J Control Release; 2022 Aug; 348():518-536. PubMed ID: 35709876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.
    Azzi S; Bruno S; Giron-Michel J; Clay D; Devocelle A; Croce M; Ferrini S; Chouaib S; Vazquez A; Charpentier B; Camussi G; Azzarone B; Eid P
    J Natl Cancer Inst; 2011 Dec; 103(24):1884-98. PubMed ID: 22043039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
    Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
    Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy targeting cancer stem cells: current views and future perspectives.
    Ogawa K; Yoshioka Y; Isohashi F; Seo Y; Yoshida K; Yamazaki H
    Anticancer Res; 2013 Mar; 33(3):747-54. PubMed ID: 23482741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem cell-targeted therapeutics and delivery strategies.
    Ahmad G; Amiji MM
    Expert Opin Drug Deliv; 2017 Aug; 14(8):997-1008. PubMed ID: 27866420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The concept and significance of cancer stem cells].
    Haraguchi N; ishii H; Sakai D; Satoh T; Doki Y; Mori M
    Nihon Geka Gakkai Zasshi; 2012 Mar; 113(2):204-9. PubMed ID: 22582581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can lung cancer stem cells be targeted for therapies?
    Wu X; Chen H; Wang X
    Cancer Treat Rev; 2012 Oct; 38(6):580-8. PubMed ID: 22436486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches for targeting cancer stem cells drug resistance.
    Rosa R; D'Amato V; De Placido S; Bianco R
    Expert Opin Drug Discov; 2016 Dec; 11(12):1201-1212. PubMed ID: 27700193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.